IncobotulinumtoxinA versus onabotulinumtoxinA in the treatment of glabellar facial lines: Results from a multicenter, randomized, doubleblinded trial

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2016
This article has no abstract
Epistemonikos ID: e7c4f812e2cfe983f9a0c7444f3310a18ecf4a6d
First added on: Feb 07, 2025